Found 7 matching trials
Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD) PHASE4 The purpose of this study is to understand the effects of long-term treatme...
Show More Status
Active Not Recruiting
Location
Wayne State University School of Medicine
Learn More & Join Trial
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG) PHASE2 The primary objectives of this study are to characterize the pharmacokineti...
Show More Location
Austin Neuromuscular Center
Learn More & Join Trial
Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy N/A This is an observational study to monitor female participants exposed to UP...
Show More Location
University of Colorado Denver
Learn More & Join Trial
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis PHASE2 Determine the difference in the modified Rankin score at 16 weeks in partic...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
CD19-B Cell Depletion in PAIS-ME/CFS Patients PHASE2 Post-acute infection syndromes (PAIS) are long-lasting health problems that...
Show More Location
Charité - Universitätsmedizin Berlin
Learn More & Join Trial
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases PHASE2 The main objective is to assess the safety and tolerability of inebilizumab...
Show More Location
HonorHealth Research and Innovation Institute
Learn More & Join Trial
AMG 335 Expanded Access Program for IgG4-Related Disease N/A Expanded access requests for AMG 335 may be considered for adult patients w...
Show More Location
Multiple Locations
Learn More & Join Trial